Literature DB >> 10667852

Induction of COX expression by a tobacco carcinogen: implication in lung cancer chemoprevention.

N Rioux1, A Castonguay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10667852     DOI： 10.1007/s000110050555

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  3 in total

1.  4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a component of tobacco smoke, modulates mediator release from human bronchial and alveolar epithelial cells.

Authors:  L I Proulx; M Gaudreault; V Turmel; L A Augusto; A Castonguay; E Y Bissonnette
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

2.  Immunomodulatory effects of the tobacco-specific carcinogen, NNK, on alveolar macrophages.

Authors:  M-J Therriault; L-I Proulx; A Castonguay; E Y Bissonnette
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

3.  Randomized phase II trial of sulindac for lung cancer chemoprevention.

Authors:  Paul J Limburg; Sumithra J Mandrekar; Marie Christine Aubry; Katie L Allen Ziegler; Jun Zhang; Joanne E Yi; Michael Henry; Henry D Tazelaar; Stephen Lam; Annette McWilliams; David E Midthun; Eric S Edell; Otis B Rickman; Peter Mazzone; Melvyn Tockman; John F Beamis; Carla Lamb; Michael Simoff; Charles Loprinzi; Eva Szabo; James Jett
Journal:  Lung Cancer       Date:  2012-12-20       Impact factor: 5.705
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.